You can:
Name | Neuropeptide FF receptor 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | NPFFR2 |
Synonym | NPFF2 receptor Neuropeptide G-protein coupled receptor GPR74 G-protein coupled receptor HLWAR77 G-protein coupled receptor 74 [ Show all ] |
Disease | N/A |
Length | 522 |
Amino acid sequence | MNSFFGTPAASWCLLESDVSSAPDKEAGRERRALSVQQRGGPAWSGSLEWSRQSAGDRRRLGLSRQTAKSSWSRSRDRTCCCRRAWWILVPAADRARRERFIMNEKWDTNSSENWHPIWNVNDTKHHLYSDINITYVNYYLHQPQVAAIFIISYFLIFFLCMMGNTVVCFIVMRNKHMHTVTNLFILNLAISDLLVGIFCMPITLLDNIIAGWPFGNTMCKISGLVQGISVAASVFTLVAIAVDRFQCVVYPFKPKLTIKTAFVIIMIIWVLAITIMSPSAVMLHVQEEKYYRVRLNSQNKTSPVYWCREDWPNQEMRKIYTTVLFANIYLAPLSLIVIMYGRIGISLFRAAVPHTGRKNQEQWHVVSRKKQKIIKMLLIVALLFILSWLPLWTLMMLSDYADLSPNELQIINIYIYPFAHWLAFGNSSVNPIIYGFFNENFRRGFQEAFQLQLCQKRAKPMEAYALKAKSHVLINTSNQLVQESTFQNPHGETLLYRKSAEKPQQELVMEELKETTNSSEI |
UniProt | Q9Y5X5 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL5952 |
IUPHAR | 301 |
DrugBank | N/A |
Name | Neuropeptide FF |
---|---|
Molecular formula | C54H76N14O10 |
IUPAC name | (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide |
Molecular weight | 1081.29 |
Hydrogen bond acceptor | 12 |
Hydrogen bond donor | 12 |
XlogP | -0.3 |
Synonyms | Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe amide, >=95% (HPLC) B5386 MFCD00076704 2-{[1-(2-{2-[2-(2-Amino-3-phenyl-propionylamino)-4-methyl-pentanoylamino]-3-phenyl-propionylamino}-4-carbamoyl-butyryl)-pyrrolidine-2-carbonyl]-amino}-pentanedioic acid 5-amide 1-{[1-(1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butyl]-amide} CAS_235433-36-0 [ Show all ] |
Inchi Key | HWYCFZUSOBOBIN-AQJXLSMYSA-N |
Inchi ID | InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 |
PubChem CID | 9854861 |
ChEMBL | CHEMBL429731 |
IUPHAR | N/A |
BindingDB | 86139, 50037557 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 2.7 nM | PMID22708927 | ChEMBL |
EC50 | 5.6 nM | PMID22708927 | ChEMBL |
EC50 | 33.0 nM | PMID22708927 | ChEMBL |
EC50 | 119.0 nM | PMID22708927 | ChEMBL |
EC50 | 126.0 nM | PMID22708927 | ChEMBL |
EC50 | 341.0 nM | PMID22708927 | ChEMBL |
EC50 | 612.0 nM | PMID22708927 | ChEMBL |
Emax | 61.0 % | PMID22708927 | ChEMBL |
Emax | 68.0 % | PMID22708927 | ChEMBL |
Emax | 86.0 % | PMID22708927 | ChEMBL |
Emax | 94.0 % | PMID22708927 | ChEMBL |
Emax | 97.0 % | PMID22708927 | ChEMBL |
Emax | 103.0 % | PMID22708927 | ChEMBL |
Emax | 109.0 % | PMID22708927 | ChEMBL |
Ki | 1.2 nM | PMID26824643 | BindingDB,ChEMBL |
Ki | 19.0 nM | PMID12606605 | BindingDB |
Ki | 37.0 nM | PMID12606605 | BindingDB |
Ratio EC50 | 2.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 3.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 19.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 70.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 74.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 200.0 - | PMID22708927 | ChEMBL |
Ratio EC50 | 360.0 - | PMID22708927 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417